Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Archives

You are currently viewing the 2000 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: erythromycin stearate

« Back to Dashboard
Erythromycin stearate is the generic ingredient in eight branded drugs marketed by Bristol, Parke Davis, Warner Chilcott, Arbor Pharms Llc, Ani Pharms Inc, Lederle, Mylan, Purepac Pharm, Watson Labs, Bristol Myers Squibb, Pfizer, and Wyeth Ayerst, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ninety-five drug master file entries for erythromycin stearate.

Summary for Generic Name: erythromycin stearate

Drug Master File Entries: see list95
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Clinical Trials for: erythromycin stearate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Wyeth Ayerst
erythromycin stearate
Tablet; Oral061675-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
erythromycin stearate
Tablet; Oral061791-001Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
erythromycin stearate
Tablet; Oral061591-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
erythromycin stearate
Tablet; Oral060359-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Zenith Goldline
erythromycin stearate
Tablet; Oral061461-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn